Where does Evoco Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Evoco Ltd. ranks #22,551 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Evoco Ltd. hold?

Evoco Ltd. holds 12 US utility patents granted between 2021 and 2025, spanning 13 technology areas.

What is Evoco Ltd.'s Innovation Score?

Evoco Ltd. has an Innovation Score of 49.1 out of 100 (top 15% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Evoco Ltd. focus on?

Evoco Ltd.'s top technology area is C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds) with 11 patents, ranking #316 of 1,741 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Evoco Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Evoco Ltd..

What does claim depth mean for Evoco Ltd.'s patents?

Evoco Ltd.'s patents average 19.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Evoco Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Evoco Ltd.

USPTO PatentsView assignee record - 12 granted patents across 13 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Evoco ranks #22,551 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 13 technology areas.

#22,551
of 49,997 US assignees by volume: Top 15%
by Innovation Score (49.1/100): 19.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R22551 · Foreign Corporation #22,551 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 12 grants
MID-PACK #22,551/49,997
PHOTO-FINISH Ethypharm
CPC-FOCUS C08G · 13 areas
INNOV-PAR 49.1/100
CLAIMS-RICH 19.9 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Ethypharm (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Evoco’s 49.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (18%) Velocity 15.6 pts (32%) Breadth 12.7 pts (26%) Claim depth 12.0 pts (24%)

Qualcomm Incorporated · highest

85
Evoco · this assignee

49
3D Lighting… · lowest

7

What this shows Evoco's Innovation Score is 49.1/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Evoco?

Each dot is one of Evoco’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Evoco’s own 19.9 claims/patent is ABOVE the 11.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Evoco vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Evoco's grants concentrate

Evoco Ltd. is a focused PatentsView assignee: 13 CPC subclasses with 91.7% of grants classified under C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds). Peak complete grant year is 2021 (3 grants) versus a trough of 2 in 2022. By volume, Evoco sits between Ethypharm and Exosect Limited.

Evoco's three-year grant acceleration

Evoco Ltd. shows 7 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Ethypharm

12
Eurokera

12
Everest Networks

12
Evertree

12
Evriholder Produc…

12
Excelerate Energy…

12
Exordium Engineer…

12
Exosect

12
Evoco ◀

12

What this shows Evoco holds 12 patents at rank #22,552, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Evoco

By rank, the assignees closest to #22,552 in granted patent volume.

Leaders in C08G (Macromolecular Compounds Obtained Otherwise Than BY React…)

Other assignees with the most granted patents in Evoco's primary technology class.

Evoco's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Evoco Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	3	25.0%
2022	2	16.7%
2023	2	16.7%
2024	3	25.0%
2025partial year	2	16.7%

Which technologies does Evoco Ltd. patent most?

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 11

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 9

C08L - Compositions OF Macromolecular Compounds 4

C07C - Acyclic OR Carbocyclic Compounds 3

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

D06N - Wall, Floor, OR Like Covering Materials, e.g. Linoleum, Oilcloth, Artificial Leather, Roofing Felt, Consisting OF A Fibrous WEB Coated With A Layer OF Macromolecular MATERIAL; Flexible Sheet Material NOT Otherwise Provided FOR 1

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 1

A43B - Characteristic Features OF FOOTWEAR; Parts OF Footwear 1

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Evoco Ltd.'s patent record in context - here's where to go next.

Evoco Ltd.'s lead technology class is C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds), 91.7% of its portfolio - see every assignee active in that class. Explore C08G
Ranked #22,551 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Evoco Ltd. against Ethypharm, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.